Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Thomas A Zelniker"'
Autor:
Eva S Schernhammer, Christian Hengstenberg, Helmuth Haslacher, Thomas Perkmann, Tanja Stamm, Christian Nitsche, Christoph J Binder, Martin Riesenhuber, Friedrich Jakse, Elaaha Anwari, Fardin Hamidi, Thomas A Zelniker
Publikováno v:
BMJ Open, Vol 13, Iss 1 (2023)
Objectives This study aimed to estimate and compare the prevalence of the virus-specific antibodies against the SARS-CoV-2 nucleoprotein antigen (anti-SARS-CoV-2 N) in healthcare workers and an all-comer paediatric and adult patient population.Design
Externí odkaz:
https://doaj.org/article/cf0609ce421244e49b3069233d78303e
Autor:
Thomas A Zelniker, Eugene Braunwald
Publikováno v:
Cardiac Failure Review, Vol 5, Iss 1, Pp 27-30 (2019)
Patients with type 2 diabetes are at increased risk of developing heart failure, cardiovascular death and renal failure. The recent results of three large sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials have demonstrated a red
Externí odkaz:
https://doaj.org/article/841865a83ad748579e673a5628ea7f0f
Autor:
Thomas A. Zelniker, Ziya Kaya, Eva Gamerdinger, Sebastian Spaich, Jan Stiepak, Evangelos Giannitsis, Hugo A. Katus, Michael R. Preusch
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Biomarkers that reflect hemodynamic stress, inflammation, extracellular matrix remodeling, angiogenesis, and endothelial dysfunction may improve risk stratification and add valuable pathobiological insight in patients with out-of-hospital ca
Externí odkaz:
https://doaj.org/article/239a66f8605e48ec9d3aa7dba288ce58
Autor:
Sebastian Spaich, Hanna Kern, Thomas A. Zelniker, Jan Stiepak, Michael Gabel, Erik Popp, Hugo A. Katus, Michael R. Preusch
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 7 (2020)
Background: This study explores the application of CardioSecur® (CS-ECG), a hand-held 4-electrode/22-lead ECG-device, in comparison with conventional 12-lead electrocardiogram (c12L-ECG) in patients with acute chest pain in the prehospital emergency
Externí odkaz:
https://doaj.org/article/8117a6b9f2f1426ea3804df1e4a9bcd1
Autor:
Remo H.M. Furtado, Marcela G. Juliasz, Felipe Y.J. Chiu, Livia B.C. Bastos, Talia F. Dalcoquio, Felipe G. Lima, Renato Rosa, Cesar A. Caporrino, Adriadne Bertolin, Paulo R.R. Genestreti, Andre S. Ribeiro, Maria Carolina Andrade, Roberto R.C.V. Giraldez, Luciano M. Baracioli, Thomas A. Zelniker, Jose C. Nicolau
Publikováno v:
ESC Heart Failure. 10:442-452
Left ventricular ejection fraction (LVEF) ≤ 40% is a well-established risk factor for mortality after acute coronary syndromes (ACS). However, the long-term prognostic impact of mildly reduced ejection fraction (EF) (LVEF 41-49%) after ACS remains
Autor:
Ofri Mosenzon, Itamar Raz, Stephen D. Wiviott, Meir Schechter, Erica L. Goodrich, Ilan Yanuv, Aliza Rozenberg, Sabina A. Murphy, Thomas A. Zelniker, Anna Maria Langkilde, Ingrid A.M. Gause-Nilsson, Martin Fredriksson, Peter A. Johansson, John P.H. Wilding, Darren K. McGuire, Deepak L. Bhatt, Lawrence A. Leiter, Avivit Cahn, Jamie P. Dwyer, Hiddo J.L. Heerspink, Marc S. Sabatine
Publikováno v:
Diabetes Care, 45(10), 2350-2359. AMER DIABETES ASSOC
OBJECTIVE In patients with moderate to severe albuminuric kidney disease, sodium–glucose cotransporter 2 inhibitors reduce the risk of kidney disease progression. These post hoc analyses assess the effects of dapagliflozin on kidney function declin
Autor:
Katharina Schütt, Jens Aberle, Johann Bauersachs, Andreas Birkenfeld, Stefan Frantz, Manfred Ganz, Stephan Jacob, Monika Kellerer, Matthias Leschke, Christoph Liebetrau, Nikolaus Marx, Dirk Müller-Wieland, Philip Raake, Paul Christian Schulze, Diethelm Tschöpe, Stephan von Haehling, Thomas A. Zelniker, Thomas Forst
Publikováno v:
Diabetol. Stoffwechs. 17, 277-288 (2022)
ZusammenfassungDiabetes mellitus (DM) stellt eine wichtige Komorbidität bei Patienten mit Herzinsuffizienz dar, die maßgeblich die Prognose der Patienten determiniert. Von entscheidender Bedeutung zur Verbesserung der Prognose dieser Hochrisiko-Pat
Autor:
Mariann Gyöngyösi, Dominika Lukovic, Julia Mester Tonczar, Katrin Zlabinger, Patrick Einzinger, Andreas Spannbauer, Victor Schweiger, Katharina Schefberger, Eslam Samaha, Jutta Bergler-Klein, Martin Riesenhuber, Christian Nitsche, Christian Hengstenberg, Patrick Mucher, Helmuth Haslacher, Monika Breuer, Robert Strassl, Elisabeth Puchhammer Stöckl, Christian Loewe, Dietrich Beitzke, Ena Hasimbegovic, Thomas A. Zelniker
Epstein-Barr virus (EBV) reactivation may be involved in long-COVID symptoms. Here we evaluated reactivation of parvovirus B19 and several viruses of the herpes family in patients with long-COVID syndrome, how vaccination affected viral interference,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ed33506a50d42138ad37dda141ebc5a
https://doi.org/10.21203/rs.3.rs-2627410/v1
https://doi.org/10.21203/rs.3.rs-2627410/v1
Autor:
Thomas A Zelniker, Dominik Schwall, Fardin Hamidi, Simone Steinbach, Pascal Scheller, Sebastian Spaich, Guido Michels, Evangelos Giannitsis, Hugo A Katus, Norbert Frey, Michael R Preusch
Publikováno v:
European Heart Journal. Acute Cardiovascular Care.
Aims Adrenomedullin (ADM) is a free-circulating peptide that regulates endothelial barrier function and vascular tone. Here, we sought to study the relationship of ADM in combination with lactate and the risk of death in patients with out-of-hospital
Autor:
Felix Hofer, Andreas Hammer, Ulrike Pailer, Lorenz Koller, Niema Kazem, Eva Steinacher, Barbara Steinlechner, Martin Andreas, Günther Laufer, Johann Wojta, Thomas A. Zelniker, Christian Hengstenberg, Alexander Niessner, Patrick Sulzgruber
Publikováno v:
Journal of the American Heart Association. 12
Background Fibroblast growth factor 23 (FGF‐23) is crucial in regulating phosphate and vitamin D metabolism and is moreover associated with an increased cardiovascular risk. The specific objective of this study was to investigate the influence of F